Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: A Gynecologic Oncology Group study in United States

International Journal of Cancer

Volumn 125, Issue 10, 2009, Pages 2434-2440

  Liao, Shu Yuan ^a,i   Rodgers, William H ^b   Kauderer, James ^c   Bonfiglio, Thomas A ^d   Walker, Joan L ^e   Darcy, Kathleen M ^c   Carter, Randy ^c   Hatae, Masayuji ^f   Levine, Lyuba ^g   Spirtos, Nick M ^h   Stanbridge, Eric J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LENOX HILL HOSPITAL   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^f Kagoshima City Hospital   (Japan)

^g University of Texas Medical Branch School of Medicine   (United States)

^h UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

ⁱ ST JOSEPH HOSPITAL   (United States)

Author keywords

AGC diagnosis; CA IX; Cervix; HPV

Indexed keywords

CARBONATE DEHYDRATASE IX;

ADULT; AGED; ARTICLE; ATYPICAL GLANDULAR CELL; CANCER INVASION; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; ENDOCRINE CELL; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREDICTIVE VALIDITY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; VIRUS DETECTION; WART VIRUS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTODIAGNOSIS; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 70349861909     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24615     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States: a 24-year population-based study. Gynecol Oncol 2000;78:97-105.
3. Anonymous. The Bethesda System for reporting cervical/vaginal cytologic diagnosis: revised after the second National Cancer Institute Workshop, April 29-30, 1991. Acta Cytol 1993;37:115-124
4. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Jr, Young N; Forum Group Members; Bethesda, 2001 Workshop. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119
5. Lee KR, Darragh TM, Joste NE, Krane JF, Sherman ME, Hurley LB, Allred EM, Manos MM. Atypical glandular cells of undetermined significance (AGUS): interobserver reproducibility in cervical smears and corresponding thin-layer preparations. Am J Clin Pathol 2002;117:96-102. (Pubitemid 34052478)
6. Liao SY, Stanbridge EJ. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia. Cancer 2000;88:1108-1121
7. Kennedy AW, Salmieri SS, Wirth SL, Biscotti CV, Tuason LJ, Travarca MJ. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening. Gynecol Oncol 1996;3:14-18
8. Veljovich DS, Stoler MH, Andersen WA, Covell JL, Rice LW. Atypical glandular cells of undetermined significance: a five-year retrospective histopathologic study. Am J Obstet Gynecol 1998;179:382-390 (Pubitemid 28413373)
9. Cangiarella JF, Chhieng DC. Atypical glandular cells-an update. Diagn Cytopathol 2003;29:271-279
10. Andersen ES, Arffmann E. Adenocarcinoma in situ of the uterine cervix: a clinico-pathologic study of 36 cases. Gynecol Oncol 1989;35:1-7. (Pubitemid 19257736)
11. Hecht JL, Sheets EE, Lee KR. Atypical glandular cells of undetermined significance (AGUS) in conventional cervical/vaginal smears and thin-layer preparations. Cancer 2002;96:1-4. (Pubitemid 34194313)
12. Ronnett BM, Manos MM, Ransley JE, Fetterman BJ, Kinney WK, Hurley LB, Ngai JS, Kurman RJ, Sherman ME. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 1999;30:816-825
13. Zavada J, Zavadova Z, Pastorekova S, Ciampor F, Pastorek J, Zelnik V. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int J Cancer 1993;54:268-274 (Pubitemid 23154893)
14. Pastorek J, Pastoreková S, Callebaut I, Mornon JP, Zelnik V, Opavský R, Zat'ovicová M, Liao S, Portetelle D, Stanbridge EJ. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 1994;9:2877-2888
15. Liao SY, Brewer C, Závada J, Pastorek J, Pastorekova S, Manetta A, Berman ML, DiSaia PJ, Stanbridge EJ. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinoma. Am J Pathol 1994;145:598-609. (Pubitemid 24285967)
16. Liao SY, Aurelio ON, Jan K, Závada J, Stanbridge EJ. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res 1997;57:2827-2831 (Pubitemid 27315020)
17. Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miaqkova A, Tarasova N, Weirich G, Merrill MJ, Proescholdt MA, Oldfield EH, Lee J, Zavada J, Waheed A, et al. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 2001;158:905-919 (Pubitemid 32221783)
18. Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, Gatter KC, Ratcliffe P, Harris AL. Prognostic significance of a novel hypoxia- regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 2001;19:3660-3668 (Pubitemid 32786278)
19. Loncaster JA, Harris AL, Davidson SE, Logue JP, Hunter RD, Wycoff CC, Pastorek J, Ratcliffe PJ, Stratford IJ, West CM. Carbonic anhydrase( CA-IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 2001;61:6394-6399 (Pubitemid 32783244)
20. Liao SY, Stanbridge EJ. Expression of the MN antigen in cervical Papanicolaou smears is an early diagnostic biomarker of cervical dysplasia. Cancer Epidemiol Biomarkers Prev 1996;5:549-557
21. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Munoz N. Epidemiology and natural history of human papillomavirus infections and type specific implications in cervical neoplasia. Vaccine 2008;26(Suppl 10):K1-K16.
22. Pirog EC, Kleter B, Olgac S, Bobkiewicz P, Lindeman J, Quint WG, Richart RM, Isacson C. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol 2000;157:1055-1062 (Pubitemid 30757926)
23. Wright TC, Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ; ASCCP-Sponsored Consensus Conference. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129 (Pubitemid 34437347)
24. Krane JF, Lee KR, Sun D, Yuan L, Crum CP. Atypical glandular cells of undetermined significance: outcome predictions based on human papillomavirus testing. Am J Clin Pathol 2004;121:87-92. (Pubitemid 38090158)
25. Irvin W, Evans SR, Andersen W, Jazaeri A, Taylor P, Stoler M, Pastore L, Rice L. The utility of HPV triage in the management of cytological AGC. Am J Obstet Gynecol 2005;193:559-567 (Pubitemid 41159556)
26. Saqi A, Gupta PK, Erroll M, Babiac A, Blackmun D, Mansukhani M, Vazquez M. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells. Diagn Cytopathol 2006;34:235-239
27. Kurman RJ, Solomon D. The Bethesda system: terminology for reporting cervical/vaginal cytologic diagnoses: definitions, criteria and explanatory notes for terminology and specimen adequacy. New York: Springer Verlag, 1994.
28. Gravitt PE, Schiffman M, Solomon D, Wheeler CM, Castle PE. A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomaviruses and cervical pre-cancer in ASCUS-LSIL Triage Study. Cancer Epidemiol Biomarkers Prev 2008;17:1248-1254
29. Castle PE, Sadorra M, Garcia F, Holladay EB, Kornegay J. Pilot study of a commercialized human papillomavirus (HPV) genotyping assay: comparison of HPV risk group to cytology and histology. J Clin Microbiol 2006;44:3915-3917 (Pubitemid 44737228)
30. Yamazaki H, Sasagawa T, Basha W, Segawa T, Inoue M. Hybrid capture- II and LCR-E7 PCR assays for HPV typing in cervical cytologic samples. Int J Cancer 2001;94:222-227 (Pubitemid 32911417)
31. Inoue M, Sakaguchi J, Sasagawa T, Tango M. The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population. Int J Gynecol Cancer 2006;16:1007-1013 (Pubitemid 43886718)